Modified Chemotherapy Regimen Effective in Advanced Ovarian Cancer
Women with advanced ovarian cancer lived longer and without their tumors growing after receiving a modified regimen of a standard chemotherapy drug combination.
by Thomas J. Herzog, MD, and Robert L. Coleman, MD
Women who are suspected of having ovarian cancer and women who have been diagnosed with ovarian cancer often receive a blood test to measure their CA-125 level. CA-125 is a substance found in the blood called a glycoprotein (a sugar-associated protein). It is commonly referred to as a biomarker or tumor marker because it provides information about the biological state of a disease (ovarian cancer) and is obtained by a blood sample from which a level can be measured. But it is more accurately considered a tumor associated protein because elevated CA-125 levels do not always indicate ovarian cancer, and levels can be misleading.
New Surgical Technique Shows Promising Results for Women with Cervical Cancer
A new surgical technique could allow surgeons to perform a radical hysterectomy in women with early-stage cervical cancer – with fewer complications, reduced morbidity, and a lower risk of local tumor recurrence than current surgical methods, according to an article published in The Lancet Oncology.
The National Cervical Cancer Coalition/HPV Cancer Coalition
by Sarina Araujo
(NCCC) is a grassroots nonprofit organization helping women, family members, and friends battle the personal issues related to cervical cancer and HPV (human papillomavirus) disease. The NCCC has expanded its core mission to include helping both women and men who battle issues related to all HPV cancers; therefore, the NCCC is also called the HPV Cancer Coalition.
NCCN Releases Updated Guidelines for Ovarian Cancer
At the National Comprehensive Cancer Network Annual Conference in March, Robert J. Morgan, MD, of City of Hope Comprehensive Cancer Center and chair of the NCCN Guidelines Panel for Ovarian Cancer, discussed the future of ovarian cancer and notable changes to the recently updated NCCN Clinical Practice Guidelines in Oncology™ for Ovarian Cancer. New to the Guidelines is a section on the management of allergic reactions in women receiving chemotherapy for ovarian cancer.
General Information About Cervical Cancer
Cervical cancer is a disease in which malignant (cancer) cells form in the tissues of the cervix. Cervical cancer usually develops slowly over time. Before cancer appears in the cervix, the cells of the cervix go through changes known as dysplasia, in which cells that are not normal begin to appear in the cervical tissue. Later, cancer cells start to grow and spread more deeply into the cervix and to surrounding areas.
Restoring Sexuality after Ovarian Cancer
Some treatments for ovarian cancer can cause side effects that may change the way you feel about your body or make it difficult to enjoy intimate or sexual relationships. Which side effects you experience depend on your treatment course. You may experience some or none at all. Being aware of the possible side effects may help you anticipate them and learn ways to cope with them.
Living with Cervical Cancer Therapy
The experience of being diagnosed with cervical cancer and undergoing cancer treatment may change the way you feel about your body and will affect your life in many ways. You may experience many or relatively few side effects. Being aware of the possible treatment effects may help you anticipate them and plan ways to cope.